SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

WorldFinancial

WorldFinancial (WLFI) is trending as traders discuss its potential connection to political figures and real estate tokenization, creating a mix of excitement and skepticism. Community members are actively debating its long-term utility and speculating on upcoming news related to the borrowing feature and app. Despite some concerns about market manipulation, WLFI's low coin circulation and potential for a short squeeze are fueling bullish sentiment for a possible price surge.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as investors digest the implications of a potential new browser from OpenAI, sparking debate about Google's dominance in search and advertising. The community is closely watching how this competition might impact Alphabet's revenue streams and market share, with some seeing it as a buying opportunity amidst the uncertainty. Despite concerns, analysts remain bullish, citing the company's strong position in AI and cloud computing.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy ($PRO) is trending as traders discuss potential short squeezes and its potential as a real-world asset (RWA) project on the Ethereum blockchain. Community members are actively debating price movements, with some anticipating a run to $5, while others express skepticism and caution due to recent price volatility and concerns about large holders. The conversation also includes discussions about its utility in real estate transactions and possible partnerships.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

SEV is trending due to its recent direct listing and the subsequent volatile trading, with the community debating the company's valuation, technology, and design. A major point of contention is a lawsuit claiming Aptera doesn't own the design or intellectual property, while others focus on pre-order numbers and potential for disruption in the EV market. Bullish sentiment centers around the potential for solar EVs, while bears cite concerns about the company's financials and questionable machine free factory tours.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets ($SSB) is gaining traction as community members highlight its listing on Phantom Wallet and anticipate potential breakouts. Conversations revolve around new meme tokens launching on Solana, with community members expressing excitement for coins like $SOLYCAT, $BALLIN, and $PJ. Several users are closely watching projects on pump.fun, looking for the next big opportunity in the meme coin space.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz is trending as chatter around a potential short squeeze intensifies, fueled by high short interest and a new partnership with Amazon to sell used vehicles. Community members are actively discussing potential price targets and monitoring key technical indicators, while also weighing the company's debt against potential upside catalysts. Some investors are drawing parallels to Carvana's past performance, suggesting Hertz could see a similar surge.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors anticipate upcoming earnings, focusing on the potential impact of AI and Azure cloud growth on the company's direction. The community is actively discussing technical patterns, potential breakouts, and options strategies to capitalize on the expected movement. Broader discussions involve Microsoft's positioning within big tech and the competitive landscape of AI infrastructure.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amidst mixed sentiment, with discussions around Gravity SUV deliveries and a new partnership juxtaposed against concerns about production targets and potential dilution. Some community members express optimism about the company's technology and potential for growth, while others voice skepticism regarding its financial health and ability to compete in the EV market. The stock's recent reverse split and lack of a permanent CEO are also points of concern for investors.

Aventus Network

Aventus Network ($AVT) is trending as community members discuss its technology, Polkadot integration, and potential for enterprise appchains.  Traders are monitoring volume for a possible breakout, while others highlight its relatively low market cap and real-world partnerships. Some community members are discussing its past performance and wondering about future price targets.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as traders discuss potential bullish technical setups, including a falling wedge breakout and cup and handle formation, and anticipate a possible short squeeze given the high short interest; the community is closely watching for a breakout above key resistance levels. Some investors believe the company is undervalued, citing its strong cash position and numerous partnered programs, while others express caution due to the company's historical price action and broader market conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates

Fate Therapeutics (FATE) delivered earnings and revenue surprises of +17.14% and +190.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of +32.00% and +21.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of +33.33% and +0.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of 0.00% and -48.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Is Fate Therapeutics (FATE) Up 61.5% Since Last Earnings Report?

Fate Therapeutics' Q1 Earnings & Revenues Beat, Pipeline in Focus

Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates

Shares of Fate Therapeutics, Inc. (FATE) were in the spotlight on Monday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-receives-regenerative-medicine-advanced">said</a> that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its FT819.FT819 is an investigational and human-induced pluripotent stem cell-derived CAR T-cell product candidate in Phase 1 clinical development for treating active moderate to severe lupus, an autoimmune disease that can affect many parts of the body.CEO Bob Valamehr said that the designation recognises the therapy's potential in treating lupus. The designation allows for early interactions with the FDA and potential priority review of a product’s biologics license application requesting approval to market a biologic product, the company said.The clinical-stage biopharmaceutical company’s application for the designation included initial clinical safety and activity data from patients treated with FT819 in the ongoing phase 1 clinical trial, it said.The company added that additional clinical data from the study will be reported later in 2025.The clinical development of FT819 is supported by a $7.9 million grant from the California Institute of Regenerative Medicine (CIRM).FATE shares, however, fell by about 13% on Monday morning following the announcement.On Stocktwits, retail sentiment around Fate Therapeutics rose marginally within the ‘extremely bullish’ territory over the past 24 hours while message volume remained ‘high’.<figure class="image"><img style="aspect-ratio:650/147;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_14_at_10_32_53_AM_png_812d8deaf1.webp" alt="FATE's Sentiment Meter and Message Volume as of 10:30 a.m. ET on April 14, 2025 | Source: Stocktwits" width="650" height="147"><figcaption>FATE's Sentiment Meter and Message Volume as of 10:30 a.m. ET on April 14, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/FATE">FATE stock</a> is down by about 49% year-to-date and 84% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/soleno-launches-tablets-for-treating-hyperphagia-in-prader-willi-syndrome/chfC4VARbaE">Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Fate Therapeutics Stock Draws Investor Attention After FDA Grants Special Designation To Its CAR T-Cell Therapy: Retail Stays Optimistic

CEO Bob Valamehr said the RMAT designation recognises the therapy's potential in treating lupus.

Equity

CEO Bob Valamehr said the RMAT designation recognises the therapy's potential in treating lupus.


Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts

Latest Ratings for FATE
 DateFirmActionFromTo Mar 2022HC Wainwright & Co.MaintainsBuy Dec 2021Morgan StanleyMaintainsEqual-Weight Dec 2021WedbushUpgradesNeutralOutperform
 View More Analyst...

FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm

FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm FATE SHAREHOLDER ALERT: Kaskela...

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Fate Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

FATE
Fate Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FATE News

FATEFate Therapeutics Inc